MabCure (EM)【MBCI】銘柄情報

MabCure Inc (EM) (MBCI) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.0002

( - )

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

0.000001 52 週間の範囲 0.0005

時価総額

156.217k

前日終値

0.0002

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 2,872

発行済株式数

781,085,980

配当利回り

PER

-0

1 株当たり利益 (EPS)

-0.19

歳入

500k

純利益

-12.26M

MabCure, Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies agai... MabCure, Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure, Inc. in January 2008 to reflect its new business plan. MabCure, Inc. was founded in 2006 and is based in White Plains, New York. 詳細を表示

セクター

Technology

業界

Semiconductors And Equipment

本社

White Plains, United States

設立

2026

MabCure Inc (EM) is listed in the Technology sector of the その他OTC with ticker MBCI. The last closing price for MabCure (EM) was US$0. Over the last year, MabCure (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.0005.

MabCure (EM) currently has 781,085,980 shares in issue. The market capitalisation of MabCure (EM) is US$156,217.20 . MabCure (EM) has a price to earnings ratio (PE ratio) of -0.00.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0001	-33.3333333333	0.0003	0.0003	0.0002	5050	0.00020099	CS
4	0.0001	100	0.0001	0.0005	1.0E-6	3667	0.00025557	CS
12	0	0	0.0002	0.0005	1.0E-6	2812	0.00030536	CS
26	0.0001	100	0.0001	0.0005	1.0E-6	32010	0.0001193	CS
52	0.0001	100	0.0001	0.0005	1.0E-6	19724	0.00011735	CS
156	-0.0001	-33.3333333333	0.0003	0.009	1.0E-6	15702	0.00022404	CS
260	-0.0024	-92.3076923077	0.0026	0.0189	1.0E-6	26822	0.00451751	CS

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

MabCure Inc (EM) (MBCI)

MabCure Inc (EM) (MBCI) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

MabCure Inc (EM) について

MBCI 最新ニュース

MabCure Announces Agreement with the City University of New York Center for Advanced Technology to Validate & Evaluate Its Mo...

MabCure, Inc. Announces Completion of Its Ovarian Cancer Diagnostic Study in Thailand

MabCure Receives U$500,000.00 Licensing Fee as Well as 12.5% Ongoing Royalty for Its Prostate Cancer Diagnostic Technology

Mabcure Study Results on a New Ovarian Cancer Diagnostic Blood Test Being Presented at the Annual Meeting of the Society of G...

MabCure Inc., Corporate Update

MabCure Secures $10 Million Funding Commitment from an Institutional Investor Managed by Roswell Capital Partners

MabCure Welcomes Dr. Charles T. Tackney as New Chief Scientific Officer

MabCure Generates Tumor Specific Antibodies against Prostate Cancer Which Could Lead to a Blood/Urine Diagnostic Test for Pro...

MabCure Signs a Collaboration Agreement with a Leading Medical Center in Europe for a Study Aimed at Further Development of a...

MabCure, Inc. Files Provisional Patent in the U.S. for Ovarian Cancer Antibodies

MBCI - Frequently Asked Questions (FAQ)

MBCI 取引

MBCI Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する